CVE-2026-3912Injection vulnerabilities due to validation/sanitisation of user-supplied input in ActiveMatrix BusinessWorks and Enterprise Administrator allows information disclosure, including exposure of accessi…
Updated under an hour ago ()
Does this affect you?
It lists no affected products yet. Add what you run and Signals checks it as products are added.
No exploitation reported and no EPSS estimate yet.
Injection vulnerabilities due to validation/sanitisation of user-supplied input in ActiveMatrix BusinessWorks and Enterprise Administrator allows information disclosure, including exposure of accessible local files and host system details, and may allow manipulation of application behaviour.
- CVSS
- 8.7 HIGH (v4.0, NVD)CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:H/SC:L/SI:L/SA:L/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
- Weakness (CWE)
- CWE-20
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- Not loaded for this CVE
- Assigned by
- Not given
- NVD analysis
- Awaiting Analysis
- Record last updated
- Jun 17, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
No affected products are listed yet.
References
- https://community.tibco.com/advisories/tibco-security-advisory-march-24-2026-tibco-activematrix-businessworks-cve-2026-3912-r227/
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.